About The Study:
Celiac disease is when the body is having an immune reaction to the protein gluten. It can create inflammation and damage the small intestinal lining which can lead to many medical complications. Having celiac disease also leaves your body unable to absorb nutrients that are necessary for good health and growth. The current treatment for celiac disease is only done by maintaining a strict gluten-free diet. By avoiding gluten, the body is able to manage its symptoms and gives the small intestine an opportunity to heal.
Living a strict gluten-free diet can be challenging at times, especially when one goes out to eat at a restaurant that doesn’t include many gluten-free options. It can even be hard eating at family or friend’s homes. Rochester Clinical Research is currently conducting a study for people between the ages of 18-75 years old who are living with celiac disease. The study is testing three different dose levels of an oral medication vs. a placebo given to people who have celiac disease. RCR is seeking participants that have been diagnosed with celiac disease and have been on a strict gluten-free diet for at least 12 months but are still experiencing gastrointestinal symptoms. The study is looking to see if there is an improvement in their symptoms on this medication if they were to consume gluten.
The study is approximately 28 weeks long and includes 7 visits to the office. Compensation is available for up to $770 if you qualify to participate.
Qualifications
- Biopsy confirmed Celiac Disease
- Between the ages of 18-75 years old
- Has maintained a gluten-free diet for at least 12 months
- Does not have a presence of other inflammatory GI disorders or systemic autoimmune diseases
- Please note* many more qualifications